Now showing items 1-1 of 1

    • Human immunodeficiency virus/hepatits C virus coinfection in Spain: elimination Is feasible, but the burden of residual cirrhosis will be significant 

      Berenguer, Juan; Jarrín, Inmaculada; Pérez-Latorre, Leire; Hontañón, Víctor; Vivancos, María J.; Navarro, Jordi; Téllez, María J.; Guardiola Tey, Josep Maria; Iribarren, José A.; Rivero-Juárez, Antonio; Márquez, Manuel; Artero, Arturo; Morano, Luis; Santos, Ignacio; Moreno, Javier; Fariñas, María C.; Galindo, María J.; Hernando, María A.; Montero, Marta; Cifuentes, Carmen; Domingo, Pere; Sanz, José; Domíngez, Lourdes; Ferrero, Oscar L.; De la Fuente, Belén; Rodríguez, Carmen; Reus, Sergio; Hernández-Quero, José; Gaspar, Gabriel; Pérez-Martínez, Laura; García, Coral; Force, Lluis; Veloso, Sergio; Losa, Juan E.; Vilaró, Josep; Bernal, Enrique; Arponen, Sari; Ortí, Amat J.; Chocarro, Ángel; Teira, Ramón; Alonso, Gerardo; Silvariño, Rafael; Vegas, Ana; Geijo, Paloma; Bisbe, Josep; Esteban, Herminia; González-García, Juan; GeSIDA 8514 Study Group (Open Forum Infectious Diseases, 2018-01)
      Background: We assessed the prevalence of antibodies against hepatitis C virus (HCV-Abs) and active HCV infection in patients infected with human immunodeficiency virus (HIV) in Spain in 2016 and compared ...